["Short-term forecasts to inform the response to the Covid-19 epidemic in the UK", "A common TMPRSS2 variant protects against severe COVID-19", "Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19", "Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study", "Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort", "Symptoms and quality of life following hospitalisation for COVID-19 (Post COVID-19 Syndrome/Long COVID) in the ISARIC WHO Clinical Characterisation Protocol UK: preliminary \u2026", "Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge", "Evaluation of S/F94 as a proxy for COVID-19 severity", "An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis", "Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19", "An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients", "Sanchez Sevilla Uruchurtu A, Siggins MK, Liew F, Russell CD, Moore SC, et al.; ISARIC4C investigators", "The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity", "Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19", "Analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the growth properties of variants \u2026", "Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults", "Neurological manifestations of COVID-19 in adults and children", "Fewer COVID\u201019 Neurological Complications with Dexamethasone and Remdesivir", "Fitting models to the COVID-19 outbreak and estimating R", "Prevention of neurological complications during COVID-19: protocol for a retrospective analysis of the ISARIC4C national cohort", "The value of open-source clinical science in pandemic response: lessons from ISARIC", "Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study", "ISARIC COVID-19 Clinical Data Report: 4 October 2020", "the collaborative study participants. Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody on behalf of the ISARIC4C Investigators", "In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control", "Reply to Russo et al", "Covid-19 Case Report Form Oxford", "GWAS and meta-analysis identifies multiple new genetic mechanisms underlying severe Covid-19.", "SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures", "Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility", "The impact of viral mutations on recognition by SARS-CoV-2 specific T cells", "HIV associated with worse outcomes from COVID-19 in UK ISARIC and OpenSAFELY databases", "Adeno-associated virus 2 infection in children with non-AE hepatitis", "COVID-19 clinical research resources", "ISARIC COVID-19 clinical data report: 8 June 2020", "Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses", "A prenylated dsRNA sensor protects against severe COVID-19", "ISARIC COVID-19 Clinical Data Report issued: 15 December 2021", "Sanchez Sevilla Uruchurtu A, Siggins MK, et al; ISARIC4C investigators: Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19", "Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical \u2026", "OPTIC consortium; ISARIC4C consortium; Fry, E", "Histological evidence of pulmonary microthrombosis and vasculitis in life-threatening respiratory virus diseases", "Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves", "Establishment of 1st WHO International Standard for anti-MERS-CoV antibody", "Females in hospital with SARS-CoV-2 infection, the association with pregnancy and pregnancy outcomes: a UKOSS/ISARIC/CO-CIN investigation", "Obesity, ethnicity, and risk of critical care, mechanical ventilation, and mortality in patients admitted to hospital with COVID\u201019: analysis of the ISARIC CCP\u2010UK cohort", "Hospitalised vaccinated patients during the second wave, 11 March 2021. Scientific Advisory Group for Emergencies 2021", "Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium \u2026", "A gene locus that controls expression of ACE2 in virus infection", "Plasma steroid profiles in patients hospitalised with COVID-19-an ISARIC/WHO CCP-UK cohort study", "COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol", "Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study", "Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.", "ISARIC Clinical data report 10 february 2021", "Recovery from Covid-19 critical illness: A secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial", "Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study", "Prospective data of first 1,797 hospitalised patients with cancer and COVID-19 derived from the COVID-19 Clinical Information Network and international Severe Acute Respiratory \u2026", "Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study", "Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum", "Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study", "Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study", "ISARIC (International Severe Acute Respiratory and Emerging Infections Consortium)", "SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses", "Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration", "An international survey on the impact of COVID-19 in individuals with Down syndrome", "Importance of patient bed pathways and length of stay differences in predicting COVID-19 bed occupancy in England", "COVID-19 Clinical Information Network (CO-CIN). Females in hospital with SARS-CoV-2 infection, the association with pregnancy and pregnancy outcomes: A UKOSS", "Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19", "Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave", "Clinical Characterisation Protocol (CCP): UK version, 2020", "Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre \u2026", "Hospitalised vaccinated patients during the second wave, update April \u201821", "Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study", "Amplicon-based detection and sequencing of SARS-CoV-2 in nasopharyngeal swabs from patients with COVID-19 and identification of deletions in the viral genome that encode \u2026", "Coinfection with influenza viruses is associated with worse outcomes in severe Covid-19, an ISARIC4C/CO-CIN Report", "Mapping the human genetic architecture of COVID-19", "Evaluation of the effectiveness of remdesivir in treating severe COVID-19 using data from the ISARIC WHO Clinical characterisation protocol UK: a prospective, national cohort study", "Symptom\u2010based case definitions for COVID\u201019: Time and geographical variations for detection at hospital admission among 260,000 patients", "ISARIC4C: Multicentre cohort study on symptoms and quality of life following hospitalisation for COVID-19-preliminary results, 25 February 2021", "Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients", "Procalcitonin is not a reliable biomarker of bacterial co-infection in people with COVID-19 undergoing microbiological investigation at the time of hospital admission", "Risk of adverse outcomes in patients with underlying respiratory conditions hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: a national \u2026", "Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol", "Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study", "Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort", "Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth \u2026", "Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population", "ISARIC COVID-19 Clinical Data Report: 13 July 2020", "Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the \u2026", "Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study", "Symptoms at presentation for patients admitted to hospital with Covid-19: results from the ISARIC prospective multinational observational study", "A common TMPRSS2 variant has a protective effect against severe COVID-19", "Detection and quantification of antibody to SARS-CoV-2 receptor binding domain provides enhanced sensitivity, specificity and utility", "Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity", "Comparative evaluation of ten lateral flow immunoassays to detect SARS-CoV-2 antibodies", "Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study", "Medical vulnerability of individuals with Down syndrome to severe COVID-19\u2013data from the Trisomy 21 Research Society and the UK ISARIC4C survey", "Oxford Immunology Network Covid-19 Response T cell Consortium; ISARIC4C Investigators, Cornall RJ, Conlon CP, Klenerman P, Screaton GR, Mongkolsapaya J, McMichael A, Knight JC \u2026", "Circulating histones play a central role in COVID-19-associated coagulopathy and mortality", "Neurological Presentations and In-Hospital Complications of COVID-19 in Adults and Children: A Large Prospective Multicentre Observational Study from the International Severe \u2026", "Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID\u201019", "A haemagglutination test for rapid detection of antibodies to SARS-CoV-2", "Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number", "Negative regulation of ACE2 by interferons in vivo and its genetic control.", "Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19", "Imperial College COVID-19 Response Team, ISARIC4C Investigators", "Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19", "Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration", "Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score", "Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK", "COVID-19 symptoms at hospital admission vary with age and sex: ISARIC multinational study", "Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study", "the COVID-19 Genomics UK (COG-UK) consortium, The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity", "Genetic mechanisms of critical illness in COVID-19", "Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity", "The UK hibernated pandemic influenza research portfolio: triggered for COVID-19", "Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study", "Changes in UK hospital mortality in the first wave of COVID-19: the ISARIC who clinical characterisation protocol prospective multicentre observational cohort study", "International Severe Acute Respiratory and Emerging Infection Consortium", "1H NMR Signals from Urine Excreted Protein Are a Source of Bias in Probabilistic Quotient Normalization", "Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England", "Admission blood glucose level and its association with cardiovascular and renal complications in patients hospitalized with COVID-19", "Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients", "Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol", "Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors\u2013a pilot study of the value of serology to determine population exposure", "What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol", "Hospitalised Vaccinated Patients during the Second Wave", "ISARIC clinical data report issued: 14 July 2021", "ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19", "ISARIC Clinical Data Report 3 September 2020", "The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020", "Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study", "OPTIC consortium; ISARIC4C consortium, NG Paterson, MA Williams, DR Hall, J. Mongkolsapaya, EE Fry, W. Dejnirattisai, J. Ren, DI Stuart, GR Screaton, Potent cross-reactive \u2026", "Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020", "Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study", "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study", "Hospital admission for symptomatic COVID\u201019 and impact of vaccination: analysis of linked data from the Coronavirus Clinical Information Network and the National Immunisation \u2026", "Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the who ISARIC CCP-UK prospective cohort study", "A Prenylated dsRNA Sensor Protects Against Severe COVID-19 and is Absent in Horseshoe Bats", "Hospital-acquired SARS-CoV-2 infection in UK", "Robust, reproducible clinical patterns in hospitalised patients with COVID-19", "Identification and quantification of SARS-CoV-2 leader subgenomic mRNA gene junctions in nasopharyngeal samples shows phasic transcription in animal models of COVID-19 and \u2026", "Towards nationally curated data archives for clinical radiology image analysis at scale: Learnings from national data collection in response to a pandemic", "ISARIC Working Group 3, ISARIC Council", "A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process", "Impact of dexamethasone and remdesivir on neurological complications during COVID-19", "Global outbreak research: harmony not hegemony", "on behalf of the ISARIC4C investigators. Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19", "Cycle threshold values are inversely associated with poorer outcomes in hospitalized patients with COVID-19: a prospective, observational cohort study conducted at a UK \u2026", "Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol", "Rapid selection of P323L in the SARS-CoV-2 polymerase (NSP12) in humans and non-human primate models and confers a large plaque phenotype", "International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 Report: 06 May 2020", "ISARIC clinical data report 20 November 2020", "Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital \u2026", "Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody on behalf of the ISARIC4C Investigators", "Erratum: Department of Error (The Lancet (2021) 398 (10296)(223\u2013237),(S0140673621007996),(10.1016/S0140-6736 (21) 00799-6))", "Further antibody escape by Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum", "Understanding severe coronavirus disease in humans from the analysis of clinical samples with RNA sequencing", "Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19", "ISARIC coronavirus clinical characterisation consortium", "Sanchez Sevilla Uruchurtu A, Siggins MK, et al", "Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational \u2026", "Clonal hematopoiesis is not significantly associated with COVID-19 disease severity", "Clinical characterisation protocol (CCP): ISARIC, 2012", "COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study"]